Dare Bioscience, Inc. Operating Lease, Payments
Dare Bioscience, Inc. (DARE) reported Operating Lease, Payments of $169.58 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-13
- Dare Bioscience, Inc. operating lease, payments for the quarter ending 2026-06-30 was $169.58K, a 3.09% increase year-over-year.
- Dare Bioscience, Inc. operating lease, payments for the quarter ending 2026-03-31 was $169.58K, a 3.09% increase year-over-year.
- Dare Bioscience, Inc. operating lease, payments for the quarter ending 2025-12-31 was $165.73K, a 21.30% increase year-over-year.
- Dare Bioscience, Inc. operating lease, payments for the quarter ending 2025-09-30 was $164.90K, a 2.93% increase year-over-year.
- Dare Bioscience, Inc. operating lease, payments for fiscal 2025 was $659.63K, a 7.20% increase from fiscal 2024.
- Dare Bioscience, Inc. operating lease, payments for fiscal 2024 was $615.33K, a 53.83% increase from fiscal 2023.
- Dare Bioscience, Inc. operating lease, payments for fiscal 2023 was $400.00K, a 33.33% increase from fiscal 2022.
- Dare Bioscience, Inc. operating lease, payments for fiscal 2022 was $300.00K, a 35.06% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $169.58K 10-Q · filed 2026-08-13 | $339.15K 10-Q · filed 2026-08-13 | $504.88K derived: sum of 3 quarters · filed 2026-08-13 | $669.78K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $169.58K 10-Q · filed 2026-05-14 | $335.30K derived: sum of 2 quarters · filed 2026-05-14 | $500.20K derived: sum of 3 quarters · filed 2026-05-14 | $664.69K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $165.73K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $330.63K derived: sum of 2 quarters · filed 2026-03-26 | $495.12K derived: sum of 3 quarters · filed 2026-08-13 | $659.63K 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $164.90K 10-Q · filed 2025-11-13 | $329.39K derived: sum of 2 quarters · filed 2026-08-13 | $493.90K 10-Q · filed 2025-11-13 | $630.50K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $164.49K 10-Q · filed 2026-08-13 | $164.00K 10-Q · filed 2025-08-14 | $328.98K 10-Q · filed 2026-08-13 | $329.00K 10-Q · filed 2025-08-14 | $465.61K derived: sum of 3 quarters · filed 2026-08-13 | $625.80K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $164.49K 10-Q · filed 2026-05-14 | $164.00K 10-Q · filed 2025-05-13 | $301.12K derived: sum of 2 quarters · filed 2026-05-14 | $461.31K derived: sum of 3 quarters · filed 2026-05-14 | $620.32K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $136.63K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $296.82K derived: sum of 2 quarters · filed 2026-03-26 | $455.82K derived: sum of 3 quarters · filed 2026-03-26 | $615.33K 10-K · filed 2026-03-26 | $600.00K 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $160.20K 10-Q · filed 2025-11-13 | $160.00K 10-Q · filed 2024-11-14 | $319.20K derived: sum of 2 quarters · filed 2025-11-13 | $478.70K 10-Q · filed 2025-11-13 | $479.00K 10-Q · filed 2024-11-14 | $563.43K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $159.00K 10-Q · filed 2025-08-14 | $318.00K 10-Q · filed 2025-08-14 | $403.23K derived: sum of 3 quarters · filed 2025-08-14 | $508.74K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $159.00K 10-Q · filed 2025-05-13 | $244.23K derived: sum of 2 quarters · filed 2025-05-13 | $349.74K derived: sum of 3 quarters · filed 2025-05-13 | $454.74K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $85.23K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $190.74K derived: sum of 2 quarters · filed 2025-03-31 | $295.74K derived: sum of 3 quarters · filed 2025-03-31 | $400.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $105.52K 10-Q · filed 2024-11-14 | $210.52K derived: sum of 2 quarters · filed 2024-11-14 | $314.77K 10-Q · filed 2024-11-14 | $384.52K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $105.00K 10-Q · filed 2024-08-12 | $209.00K 10-Q · filed 2024-08-12 | $279.00K derived: sum of 3 quarters · filed 2024-08-12 | $360.00K derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $105.00K 10-Q · filed 2024-05-14 | $174.00K derived: sum of 2 quarters · filed 2024-05-14 | $255.00K derived: sum of 3 quarters · filed 2024-05-14 | $335.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $150.00K derived: sum of 2 quarters · filed 2024-03-28 | $230.00K derived: sum of 3 quarters · filed 2024-03-28 | $300.00K 10-K · filed 2024-03-28 | $346.00K 10-K · filed 2023-03-30 | |||
| 2022-09-30 | $81.00K 10-Q · filed 2023-11-09 | $161.00K derived: sum of 2 quarters · filed 2023-11-09 | $231.00K 10-Q · filed 2023-11-09 | $403.00K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $80.00K 10-Q · filed 2023-08-10 | $203.00K 10-Q · filed 2023-08-10 | $322.00K derived: sum of 3 quarters · filed 2023-08-10 | $439.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $123.00K 10-Q · filed 2023-05-11 | $242.00K derived: sum of 2 quarters · filed 2023-05-11 | $359.00K derived: sum of 3 quarters · filed 2023-05-11 | $473.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $236.00K derived: sum of 2 quarters · filed 2023-03-30 | $350.00K derived: sum of 3 quarters · filed 2023-03-30 | $462.00K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $117.00K 10-Q · filed 2022-11-10 | $231.00K derived: sum of 2 quarters · filed 2022-11-10 | $343.00K 10-Q · filed 2022-11-10 | $455.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $114.00K 10-Q · filed 2022-08-09 | $226.00K 10-Q · filed 2022-08-09 | $338.00K derived: sum of 3 quarters · filed 2022-08-09 | $449.00K derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $112.00K 10-Q · filed 2022-05-12 | $224.00K derived: sum of 2 quarters · filed 2022-05-12 | $335.00K derived: sum of 3 quarters · filed 2022-05-12 | $445.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $223.00K derived: sum of 2 quarters · filed 2021-11-10 | $333.00K derived: sum of 3 quarters · filed 2021-11-10 | $461.00K 10-K · filed 2021-03-30 | ||||
| 2020-09-30 | $111.00K 10-Q · filed 2021-11-10 | $221.00K derived: sum of 2 quarters · filed 2021-11-10 | $349.00K 10-Q · filed 2021-11-10 | $422.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $110.00K 10-Q · filed 2021-08-12 | $238.00K 10-Q · filed 2021-08-12 | $311.00K derived: sum of 3 quarters · filed 2021-08-12 | $339.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $128.00K 10-Q · filed 2021-05-13 | $201.00K derived: sum of 2 quarters · filed 2021-05-13 | $229.00K derived: sum of 3 quarters · filed 2021-05-13 | $256.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $101.00K derived: sum of 2 quarters · filed 2020-11-12 | $128.00K derived: sum of 3 quarters · filed 2020-11-12 | $154.00K 10-K · filed 2020-03-27 | ||||
| 2019-09-30 | $28.00K 10-Q · filed 2020-11-12 | $27.66K 10-Q · filed 2019-11-12 | $55.00K derived: sum of 2 quarters · filed 2020-11-12 | $81.00K 10-Q · filed 2020-11-12 | $80.91K 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $27.00K 10-Q · filed 2020-08-12 | $26.62K 10-Q · filed 2019-08-14 | $53.00K 10-Q · filed 2020-08-12 | $53.24K 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | $27.00K 10-Q · filed 2020-05-14 | $26.62K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |